Literature DB >> 21191624

The effects of pargyline and 2-phenylethylamine on D1-like dopamine receptor binding.

Mark D Berry1.   

Abstract

2-Phenylethylamine (PE) potentiates neuronal responses to dopamine by an unknown post-synaptic mechanism. Here, whether PE modifies D1-like receptor binding was examined. An unexpected effect of the monoamine oxidase inhibitor pargyline was observed, which did not involve competition for ligand binding. PE did not affect ligand binding in the presence or absence of pargyline. It is concluded that the effect of pargyline does not involve elevation of endogenous PE, and PE effects on dopaminergic neurotransmission are not due to altered D1-like receptor binding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191624     DOI: 10.1007/s00702-010-0561-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  28 in total

1.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Authors:  J R Bunzow; M S Sonders; S Arttamangkul; L M Harrison; G Zhang; D I Quigley; T Darland; K L Suchland; S Pasumamula; J L Kennedy; S B Olson; R E Magenis; S G Amara; D K Grandy
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

2.  Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1.

Authors:  David B Wainscott; Sheila P Little; Tinggui Yin; Yuan Tu; Vincent P Rocco; John X He; David L Nelson
Journal:  J Pharmacol Exp Ther       Date:  2006-10-12       Impact factor: 4.030

3.  Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

Authors:  W Billard; V Ruperto; G Crosby; L C Iorio; A Barnett
Journal:  Life Sci       Date:  1984-10-29       Impact factor: 5.037

4.  Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.

Authors:  M Y Zhu; A V Juorio; I A Paterson; A A Boulton
Journal:  Eur J Pharmacol       Date:  1993-07-20       Impact factor: 4.432

5.  Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

6.  The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.

Authors:  Amyaouch Bradaia; Gerhard Trube; Henri Stalder; Roger D Norcross; Laurence Ozmen; Joseph G Wettstein; Audrée Pinard; Danièle Buchy; Martin Gassmann; Marius C Hoener; Bernhard Bettler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

7.  A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain.

Authors:  Zhihua Xie; Gregory M Miller
Journal:  J Pharmacol Exp Ther       Date:  2009-04-13       Impact factor: 4.030

8.  beta-Phenylethylamine enhances single cortical neurone responses to noradrenaline in the rat.

Authors:  I A Paterson; A A Boulton
Journal:  Brain Res Bull       Date:  1988-02       Impact factor: 4.077

9.  The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine.

Authors:  M D Berry; E Scarr; M Y Zhu; I A Paterson; A V Juorio
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

Review 10.  2-Phenylethylamine-induced changes in catecholamine receptor density: implications for antidepressant drug action.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

View more
  1 in total

1.  D1 Antagonists and D2 Agonists Have Opposite Effects on the Metabolism of Dopamine in the Rat Striatum.

Authors:  Alberto Avila-Luna; Jacqueline Prieto-Leyva; Arturo Gálvez-Rosas; Alfonso Alfaro-Rodriguez; Rigoberto Gonzalez-Pina; Antonio Bueno-Nava
Journal:  Neurochem Res       Date:  2015-05-17       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.